Why Andreessen Horowitz’s Julie Yoo sees AI as a ‘leapfrog opportunity’ for healthcare

The Silicon Valley venture firm Andreessen Horowitz in recent years has been investing heavily in healthcare and biotech, guided by its well-known mantra that “software will eat the world.”

The investing team, which has $35 billion under management, in 2019 charged general partner Julie Yoo to apply the thesis to the doctor’s office and see if software could eat care delivery, too. Before her time in VC, Yoo co-founded Kyruus, an enterprise software company for health systems.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

USPSTF: No Thumbs Up for Screening All Kids for Speech Delay

The U.S. Preventive Services Task Force (USPSTF) concluded that there is not enough evidence to make a recommendation on primary care screening for speech and

July 26, 2023

Tennessee tries to rein in Ballad’s hospital monopoly after years of problems

Ballad Health, an Appalachian company with the nation’s largest state-sanctioned hospital monopoly, may soon be required to improve its quality of care or face the

September 18, 2024

LungVax vaccine uses DNA technology to prevent lung cancer

Developed by scientists from the University of Oxford, the Francis Crick Institute and University College London, the LungVax vaccine uses technology similar to the highly

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.